Zealand Pharma A/S

ZEAL.CO·Copenhagen·Healthcare
Compare
240.70+3.70 (+1.56%)today
As of Nov 5, 1:33 PM CET · May be delayed up to 15 min · DKK

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close237.00
Open240.40
Day range238.80242.50
52-week range220.60556.00
Off day high−0.74%
Off 52-week high−56.71%
Volume163.93K
Avg. volume (3M)385.37K
Market cap15.97B
EPS (TTM)38.64
Forward P/E33.74
P/E ratio (TTM)6.23
Dividend yield—
Beta (5Y)0.46
Shares outstanding66.33M
Short interest—
Earnings dateNov 12, 2026
Analyst target396.00
Profit margin59.02%

Against its peers

Compare in full ›
ZEAL.CO 688166.SS BMRN ROIV ENTX KLRA
Market cap 15.97B 13.81B 11.07B 27.61B 540.90M 1.66B
P/E (TTM) 6.2 132.1 — — — —
Forward P/E 33.7 53.7 9.0 -27.5 -5.7 -3.0
Price/book 0.9 4.5 1.8 6.5 21.2 0.0
Dividend yield — 0.05% — — — —
1-year change −44.17% −44.06% +10.20% +85.85% 0.00% −50.77%
Today +1.56% +2.42% +2.64% +6.08% +1.97% +1.75%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ZEAL.CO news ›
MassBio·

Member Spotlight: Zealand Pharma A/S

Massachusetts Biotechnology Council Zealand Pharma is a biotechnology company transforming metabolic health so millions of people can live without limits. With the opening of its new research hub at 35 CambridgePark Drive, Zealand Pharma…

MarketScreener·

Zealand Pharma A/S : Insider Transactions

Follow insider transactions on Zealand Pharma A/S in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Zealand Pharma A/S Biotechnology & Medical Research Latest insider…

From the 4Search news index, newest first.

In the news

11mentions in 30 days
11with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance